Cover Image
Market Research Report

Global Nucleic Acid Testing Market, By Product Type (Nucleic Acid Test Kits (PCR, TMA, LLCR), and Whole genome sequencing) and Consumables, By End User, and Geography - Opportunities & Forecast, 2018-2025

Published by GMI Research Product code 836186
Published Content info 129 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Nucleic Acid Testing Market, By Product Type (Nucleic Acid Test Kits (PCR, TMA, LLCR), and Whole genome sequencing) and Consumables, By End User, and Geography - Opportunities & Forecast, 2018-2025
Published: May 8, 2019 Content info: 129 Pages
Description

Title:
Global Nucleic Acid Testing Market
By Product Type (Nucleic Acid Test Kits {Polymerase chain reaction (PCR), Transcription-mediated amplification (TMA), Ligase chain reaction (LCR), and Whole genome sequencing} and Consumables, By End User (Hospitals, Pathology laboratories, Research Institutes and Clinics), and Geography - Opportunities & Forecast, 2018-2025.

The global nucleic acid testing market was valued at USD 2,478.0 million in 2017 and is projected to reach USD 4,154.8 million by the end of 2025, growing at a CAGR of 6.8% during 2018-2025.

The key factors bolstering the market growth are growing awareness and rising molecular diagnosis, improving diagnosis rate in developing regions, advancement in technology and shift from curative healthcare to preventive healthcare across the globe.

Based on the product type, polymerase chain reaction segment is anticipated to lead the market during 2018-2025

Polymerase chain reaction segment is expected to hold the maximum market share of about 40% during the forecast period due to operational simplicity and high efficiency. On the other hand, ligase chain reaction segment is projected to exhibit the highest growth rate due to a number of factors, including the expansion of sequencing into new applications in the clinical and applied market segments.

Based on end user, research institutes dominate the market due to extensive research and development activities and lack of molecular diagnostic labs in developing countries, such as China, India, Brazil, etc. The end-user segment includes hospitals, pathology laboratories, research institutes and clinics. Research Institutes' segment is expected to grow at an estimated CAGR of 7.0% rate during the forecast period, owing to, rising demand for whole-genome sequencing as preventive care diagnosis grows rapidly. Also, the significant rise in demand for molecular testing for the cancer diagnosis, infectious disease, forensic and other applications are predicted to aid the market growth in the coming years.

Players, such as Abbot Laboratories, F. Hoffmann-La Roche Ltd. and Becton, Dickinson and Company are investing a lot in the research & development activities. The major companies are focusing on product launches for keeping leadership in the global nucleic acid testing market. For instance, around more than hundreds of products are in clinical pipelines for nucleic acid testing kits across the globe.

North America held the largest share in the global nucleic acid testing market in 2017 owing to the well-developed healthcare system, high disposable income, and favorable reimbursement policies. However, the fastest growth rate is expected to be exhibited by Asia-Pacific during the forecast period owing to increasing adoption of preventive diagnosis care, surging demand for blood transfusion, and government initiatives to implement nucleic acid testing in the public health services.

Various notable players operating in the market include, Abbott Laboratories, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Merck KGaA, Becton, Dickinson and Company, among others.

The global nucleic acid testing market has been segmented on the basis of product type, end use and key geographies. Based on the product type, the market comprises of polymerase chain reaction (PCR), transcription-mediated amplification (TMA), ligase chain reaction (LCR), and whole genome sequencing. The end use areas include hospitals, pathology laboratories, research institutes and clinics.

The research report provides in-depth analysis of the global nucleic acid testing market, based on product type, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for nucleic acid testing market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:

  • 1. At what pace is nucleic acid testing market growing, globally? What will be the growth trend in future?
  • 2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
  • 3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the nucleic acid testing market?
  • 4. What are the various application areas and how they are poised to grow?
Table of Contents
Product Code: HM09A-00-0818

Table of Contents

1. Executive Summary

2. Introduction:

  • 2.1. Study Objectives
  • 2.2. Scope of the Study - Markets Covered
  • 2.3. Scope of the Study - Geographical Coverage
  • 2.4. Study Years & Currency
  • 2.5. Global Nucleic Acid Testing Market Stakeholders
  • 2.6. GMI Research's Approach & Methodology
  • 2.7. Key Questions this study will answer

3. Global Global Nucleic Acid Testing Market - Overview:

  • 3.1. Introduction
  • 3.2. Market Segmentation
  • 3.3. Global Healthcare Outlook
  • 3.4. Drivers
  • 3.5. Restraints
  • 3.6. Trends

4. Global Nucleic Acid Testing Market

5. Global Nucleic Acid Testing Market - By Product Type:

  • 5.1. Global Nucleic Acid Testing Market, By Polymerase Chain Reaction Kits
  • 5.2. Global Nucleic Acid Testing Market, By Transcription-Mediated Amplification (TMA) Kits
  • 5.3. Global Nucleic Acid Testing Market, By Ligase Chain Reaction (LCR) Kits
  • 5.4. Global Nucleic Acid Testing Market, By Whole genome sequencing Kits
  • 5.5. Global Nucleic Acid Testing Market by Consumables

6. Global Nucleic Acid Testing Market - By End User:

  • 6.1. Global Nucleic Acid Testing Market, By Hospital
  • 6.2. Global Nucleic Acid Testing Market, By Pathology Laboratories57
  • 6.3. Global Nucleic Acid Testing Market, By Research Institutes
  • 6.4. Global Nucleic Acid Testing Market, By Clinics

7. Global Nucleic Acid Testing Market - By Geography:

  • 7.1. North America Nucleic Acid Testing Market
  • 7.2. Europe Nucleic Acid Testing Market
  • 7.3. Asia-Pacific Nucleic Acid Testing Market
  • 7.4. Rest of the World Nucleic Acid Testing Market

8. Competitive Landscape738.1Porter's Five Forces Analysis

9. Company Profiles789.1Bio-Rad Laboratories, Inc:

  • 9.2. Danaher Corporation
  • 9.3. illumina, Inc.
  • 9.4. Qiagen
  • 9.5. Thermo Fisher Scientific, Inc
  • 9.6. Abbott Laboratories
  • 9.7. Becton Dickinson and Company
  • 9.8. Roche Holding AG
  • 9.9. Merck KGaA
  • 9.10. Agilent Technologies

10. About GMI Research

List of Figures

  • Figure 1: Global Nucleic Acid Testing Market Revenue by Region, 20179
  • Figure 2: Global Nucleic Acid Testing Market Revenue Forecast (2018-2025)9
  • Figure 3: Global Nucleic Acid Testing Market Revenue Forecast (2018-2025), by Product Type 9
  • Figure 4: Global Nucleic Acid Testing Market, Market Revenue share, by Product Type, 20179
  • Figure 5: Global Nucleic Acid Testing Market: Segment Attractiveness by End User, 201710
  • Figure 6: Scope of the Study -- Markets Covered16
  • Figure 7: Scope of the Study -- Segmentation by Region17
  • Figure 8: Global Nucleic Acid Testing Market, Study Years18
  • Figure 9: Nucleic Acid Testing Market Stakeholders19
  • Figure 10: Research Methodology20
  • Figure 11: Key Questions this Study will Answer21
  • Figure 12: Nucleic Acid Testing Market, By Product Type25
  • Figure 13: Healthcare Expenditure % of GDP by Countries26
  • Figure 14: Global Nucleic Acid Testing Market Drivers27
  • Figure 15: Global Nucleic Acid Testing Market Drivers-Impact30
  • Figure 16: Global Nucleic Acid Testing Market Restraints31
  • Figure 17: Global Nucleic Acid Testing Market Restraints - Impact33
  • Figure 18: Global Nucleic Acid Testing Market Trends34
  • Figure 19: Global Nucleic Acid Testing, Revenue Forecast 2018--2025 (USD Million)39
  • Figure 20: Global Nucleic Acid Testing Market, by product Type, Revenue%, 201742
  • Figure 21: Global Nucleic Acid Testing Market, by product Type, Revenue%, 202542
  • Figure 22: Global Nucleic Acid Testing Market by Polymerase Chain Reaction Kits, Revenue Forecast 2018--2025 (USD Million)43
  • Figure 23: Global Nucleic Acid Testing Market by Transcription-Mediated Amplification (TMA), Revenue Forecast 2018--2025 (USD Million)45
  • Figure 24: Global Nucleic Acid Testing Market by Ligase Chain Reaction (LCR) Kits, Revenue Forecast 2018--2025 (USD Million)47
  • Figure 25: Global Nucleic Acid Testing Market by Whole genome sequencing Kits, Revenue Forecast 2018--2025 (USD Million)49
  • Figure 26: Global Nucleic Acid Testing Market by Consumables, Revenue Forecast 2018--2025 (USD Million)
  • Figure 27: Global Nucleic Acid Testing Market, by End User, Revenue% Share, 201754
  • Figure 28: Global Nucleic Acid Testing Market, by End User, Revenue% Share, 2025 54
  • Figure 29: Global Nucleic Acid Testing Market By Hospital, Revenue Forecast 2018--2025 (USD Million)55
  • Figure 30: Global Nucleic Acid Testing Market By Pathology Laboratories, Revenue Forecast 2018--2025 (USD Million)57
  • Figure 31: Global Nucleic Acid Testing Market By Research Institutes, Revenue Forecast 2018--2025 (USD Million)59
  • Figure 32: Global Nucleic Acid Testing Market By Clinics, Revenue Forecast 2018--2025 (USD Million)61
  • Figure 33: Global Nucleic Acid Testing Market, by Geography, Revenue% Share, 201764
  • Figure 34: Global Nucleic Acid Testing Market, by Geography, Revenue% Share, 202564
  • Figure 35: North America Nucleic Acid Testing Market, Revenue Forecast 2018--2025 (USD Million)65
  • Figure 36: Europe Nucleic Acid Testing Market, Revenue Forecast 2018--2025 (USD Million)67
  • Figure 37: Asia-Pacific Nucleic Acid Testing Market, Revenue Forecast 2018--2025 (USD Million)69
  • Figure 38: Rest of the World Nucleic Acid Testing Market, Revenue Forecast 2018--2025 (USD Million)71
  • Figure 39: Porter's Five Forces Analysis74
  • Figure 40: Bio-Rad Laboratories, Inc Business Segments80
  • Figure 41: Bio-Rad Laboratories Inc Revenue and Growth Rate (%), FY 2015-1781
  • Figure 42: Bio-Rad Laboratories Inc Revenue % Breakdown by Business Segment, FY 2015-1781
  • Figure 43: Bio-Rad Laboratories Inc Revenue % Breakdown by Geography, FY 201781
  • Figure 44: Danaher Corporation Business Segments84
  • Figure 45: Danaher Corporation Revenue and Growth Rate (%), FY 2015-1785
  • Figure 46: Danaher Corporation Revenue % Breakdown by Business Segment, FY 2015-1785
  • Figure 47: Danaher Corporation Revenue % Breakdown by Geography, FY 201785
  • Figure 48: illumina, Inc., Business Segments88
  • Figure 49: illumina, Inc., Revenue and Growth Rate (%), FY 2015-1789
  • Figure 50: illumina, Inc., Revenue % Breakdown by Business Segment, FY 2015-1789
  • Figure 51: illumina, Inc., Revenue % Breakdown by Geography, FY 201789
  • Figure 52: Qiagen Business Segments92
  • Figure 53: Qiagen Revenue and Growth Rate (%), FY 2015-1793
  • Figure 54: Qiagen Revenue % Breakdown by Business Segment, FY 2015-1793
  • Figure 55: Qiagen Revenue % Breakdown by Geography, FY 201793
  • Figure 56: Thermo Fisher Scientific Inc. Business Segments96
  • Figure 57: Thermo Fisher Scientific Inc. Revenue and Growth Rate (%), FY 2015-1797
  • Figure 58: Thermo Fisher Scientific Inc. Revenue% Breakdown by Business Segment, FY 2015-1797
  • Figure 59: Thermo Fisher Scientific Inc. Revenue% Breakdown by Geography, FY 201797
  • Figure 60: Abbott Laboratories Business Segments100
  • Figure 61: Abbott Laboratories Revenue and Growth Rate (%), FY15-17101
  • Figure 62: Abbott Laboratories Revenue % Breakdown by Business Segment, FY15-17101
  • Figure 63: Abbott Laboratories Revenue % Breakdown by Geography, FY17101
  • Figure 64: Becton Dickinson and Company Business Segments104
  • Figure 65: Becton Dickinson and Company Revenue and Growth Rate (%), FY 2015-17105
  • Figure 66: Becton Dickinson and Company Revenue % Breakdown by Business Segment, FY 2015-17105
  • Figure 67: Becton Dickinson and Company Revenue % Breakdown by Geography, FY 2017105
  • Figure 68: Roche Holding AG Business Segments108
  • Figure 69: Roche Holding AG Revenue and Growth Rate (%), FY 2015-17109
  • Figure 70: Roche Holding AG Revenue % Breakdown by Business Segment, FY 2015-17109
  • Figure 71: Roche Holding AG Revenue % Breakdown by Geography, FY 2017109
  • Figure 72: Merck KGaA Business Segments112
  • Figure 73: Merck KGaA Revenue and Growth Rate (%), FY 2015-17113
  • Figure 74: Merck KGaA Revenue % Breakdown by Business Segment, FY 2015-17113
  • Figure 75: Merck KGaA Revenue % Breakdown by Geography, FY 2017113
  • Figure 76: Agilent Technologies Business Segments116
  • Figure 77: Agilent Technologies Revenue and Growth Rate (%), FY 2015-17117
  • Figure 78: Agilent Technologies Revenue% Breakdown by Business Segment, FY 2015-17117

List of Tables

  • Table 1: Bio-Rad Laboratories Inc Recent Developments82
  • Table 2: Danaher Corporation Recent Developments86
  • Table 3: illumina, Inc., Recent Developments90
  • Table 4: Qiagen Recent Developments94
  • Table 5: Thermo Fisher Scientific Inc. Recent Developments98
  • Table 6: Abbott Laboratories Recent Developments102
  • Table 7: Becton Dickinson and Company Recent Developments106
  • Table 8: Roche Holding AG Recent Developments110
  • Table 9: Merck KGaA Recent Developments114
  • Table 10: Agilent Technologies Recent Developments118
Back to Top